Alnylam Pharmaceuticals
ALNY
#815
Rank
HK$235.13 B
Marketcap
HK$1,757
Share price
-1.43%
Change (1 day)
-52.74%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company